Johnson & Johnson's (JNJ) rybrevant (amivantamab-vmjw) plus lazcluze (lazertinib) demonstrates prolonged clinical benefit as a first-line treatment for atypical egfr-mutated non-small cell lung cancer

Newsquawk StaffPublished On the live feed at 4 more headlines followed before this page went public
Newsquawk headlinesUTC

President Trump posts an image stating 900k bbls of US oil have arrived in Japan, alongside a message saying "America will lead the charge on oil dominance"

President Trump shares story with US ambassador stating that the EU must honour its trade deal with the US

Johnson & Johnson's (JNJ) rybrevant (amivantamab-vmjw) plus lazcluze (lazertinib) demonstrates prolonged clinical benefit as a first-line treatment for atypical egfr-mutated non-small cell lung cancer

A US House bill targeting Chinese-linked automakers could result in a US ban on new Mercedes-Benz (MBG GY) vehicles, CNBC reports

Universal Music (UMG NA) declines unsolicited Pershing Square (PSH LN) proposal, citing undervaluation of the company

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.

Related headlines

The whole workspace, free to try.

Try it free